Arkolith/Insider Trading/DCPH/Form 4

Sherman Matthew L

EVP & Chief Medical OfficerDeciphera Pharmaceuticals, Inc. (DCPH) · full profile →Form 4 · filed Feb 17, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15K
Net Open-Market Flow
-$15K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 16, 2023Sell(S)971$15.10$15K88K
Feb 15, 2023Grant(A)16K—$089K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 15, 2023Grant(A)66K—$066K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-010506) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML